home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/38f2a00b-ebc4-42fa-a101-cbba6bd257b4_TB-White-Paper-070918-ml.pdf
whitepaper
SHARESHARESHARE
RAPID AND AFFORDABLE ANTIMICROBIAL RESISTANCE PROFILING OF TUBERCULOSIS SAMPLES
With over 10 million new cases worldwide each year and approximately 1.7 million deaths, tuberculosis (TB) is one of the leading global threats to human health. While disease detection and control methods have yielded a steady decline in the number of deaths attributable to TB, the emergence of multi-drug resistant (MDR) strains of Mycobacterium tuberculosis the predominant cause of TB is threatening to undermine this effort. Such strains are resistant to the most effective first-line drugs rifampicin and isoniazid and are associated with approximately 490,000 new cases of infection per annum1. DOWNLOAD